Based on a well-documented decreased expression pattern of TP53 gene in ccRCC tumor samples [24, 25], we decided to apply candidate RGs which showed significant under expression of TP53 in tumor samples in both normalization approaches (group II and group IV). Here, TP53 is linked to nonpapillary renal cell carcinoma.